source
- Eli Lilly Leads Both Innovation and Invention Rankings in Pharma R&D PerformanceSTAT+ reports that Eli Lilly captured the top positions in a prominent pharma R&D performance ranking, leading both the innovation and invention categories. The rankings, compiled by UK-based IDEA…
- Relay Therapeutics' zovegalisib meets efficacy endpoint in Phase 2 vascular anomalies trialRelay Therapeutics reported that its PI3Kα inhibitor zovegalisib achieved the predefined efficacy threshold in a Phase 2 study of a rare genetic vascular anomaly. The data readout exceeded Wall Str…